Brief: JW Pharmaceutical Signs $70 Mln Technology Transfer Contract With China's Nanjing Simcere Dongyuan Pharmaceutical
27/09/2019 05:21
Sept 27 (Reuters) - JW Pharmaceutical Corp 001060.KS :
* SIGNS $70 MILLION TECHNOLOGY TRANSFER CONTRACT WITH
CHINA'S
NANJING SIMCERE DONGYUAN PHARMACEUTICAL
Source text for Eikon: https://bit.ly/2lvvS4m
Further company coverage: 001060.KS
((sangmi.cha.thomsonreuters.com@reuters.net;))
Recent news on JW Pharmaceutical
See all newsBrief: Jw Pharmaceutical Q3 Operating Profit 32.6 Billion Won, Up 24% From Year Earlier
Brief: Jw Pharmaceutical Q2 Operating Profit 25.4 Billion Won, Up 103.3% From Year Earlier
Brief: Jw Pharmaceutical Q1 Operating Profit 22.6 Billion Won, Down 15.4% From Year Earlier
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares